Polar Capital Holdings’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
247,500
-852,500
| -78% | -$40.2M | 0.06% | 176 |
|
|
2025
Q1 | $43M | Hold |
1,100,000
| – | – | 0.26% | 106 |
|
|
2024
Q4 | $59.6M | Buy |
1,100,000
+600,000
| +120% | +$32.5M | 0.33% | 78 |
|
|
2024
Q3 | $25.2M | Sell |
500,000
-178,169
| -26% | -$8.98M | 0.12% | 122 |
|
|
2024
Q2 | $29.8M | Sell |
678,169
-179,788
| -21% | -$7.91M | 0.18% | 111 |
|
|
2024
Q1 | $43.1M | Sell |
857,957
-79,158
| -8% | -$3.98M | 0.23% | 95 |
|
|
2023
Q4 | $56.6M | Sell |
937,115
-1,897
| -0.2% | -$115K | 0.35% | 80 |
|
|
2023
Q3 | $53.5M | Sell |
939,012
-676,377
| -42% | -$38.6M | 0.4% | 73 |
|
|
2023
Q2 | $82.4M | Buy |
1,615,389
+739,012
| +84% | +$37.7M | 0.42% | 56 |
|
|
2023
Q1 | $18.7M | Hold |
876,377
| – | – | 0.12% | 142 |
|
|
2022
Q4 | $9.2M | Buy |
+876,377
| New | +$9.2M | 0.07% | 198 |
|